3VM for Treatment of Chronic Osteoarthritis Knee Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2017

Primary Completion Date

January 30, 2018

Study Completion Date

June 1, 2018

Conditions
Arthritis, Degenerative
Interventions
DRUG

Experimental: 3VM1001 active 2g Cream 3 times daily

3VM1001 2g Cream with active ingredient administered 3 times daily

DRUG

Experimental: 3VM1001 active 3g Cream 3 times daily

3VM1001 3g Cream with active ingredient administered 3 times daily

DRUG

Experimental: 3VM1001 active 3g Cream 4 times daily

3VM1001 3g Cream with active ingredient administered 4 times daily

DRUG

Placebo: 3VM1001 vehicle 2g Cream 3 times daily

3VM1001 placebo 2g vehicle Cream administered 3 times daily

DRUG

Placebo: 3VM1001 vehicle 3g Cream 3 times daily

3VM1001 placebo 3g vehicle Cream administered 3 times daily

DRUG

Placebo: 3VM1001 vehicle 3g Cream 4 times daily

3VM1001 placebo 3g vehicle Cream administered 4 times daily

Trial Locations (1)

43235

Optimed Research, LTD, Columbus

Sponsors
All Listed Sponsors
lead

CDA Research Group, Inc.

INDUSTRY

NCT03142178 - 3VM for Treatment of Chronic Osteoarthritis Knee Pain | Biotech Hunter | Biotech Hunter